AI analysis of bacteria and other gut microorganisms can help distinguish between people with and without multiple sclerosis, ...

Late-onset MS patients are more likely to accumulate disability through mechanisms not directly linked to relapses, per a ...

An international trial will test an app called Conscientiousness Coach that includes mindset training to target MS cognitive ...

Researchers have identified six key proteins that could be targeted to combat MS progression, and potential drugs that could ...

In an open letter, guest writer Rhonda Fuller tells her MS that she represents resilience, survival, and transformation.

An AI model predicted cognitive decline in MS with about 90% accuracy using brain scans, clinical data, and demographics.

MS relapse risk was low after age 60 whether patients continued or stopped DMTs, but MRI changes were more common than ...

Improved survival, rather than rising incidence, appears to be the main driver of increasing MS prevalence in France and ...

Columnist Ben Hofmeister says being cool under fire came from good military training, but he wasn't prepared to manage the stress of MS.

FDA clearance allows Imviva to test CTA313, an off-the-shelf CAR T-cell therapy, in progressive MS and other autoimmune ...

Among people with CIS, lower levels of certain small fatty molecules in the blood are associated with a higher relapse risk, ...

PTSD is often associated with a single event, but for people with chronic illness, the trauma can be ongoing, says columnist Ben Hofmeister.